Huons said Friday that it improved its profitability in the first quarter of 2025 by strengthening earnings across its ...

Oscotec is placing its bets on anti-resistance cancer therapies. The Korean biotech received the U.S. FDA green light to go ...

GemVax & KAEL said Friday that GV1001, its treatment for progressive supranuclear palsy (PSP), has received orphan drug ...

LG H&H’s luxury skincare brand THE WHOO has surpassed 20 trillion won ($13.9 billion) in cumulative net sales, cementing its ...

Korean researchers have found no direct link between Covid-19 vaccination and menstrual changes such as abnormal uterine ...

In Korea, Eli Lilly and Novo Nordisk are pushing for national health insurance coverage for their diabetes drugs Mounjaro and ...

Korean biotech OliX Pharmaceuticals has locked in a $3 million milestone payment from China’s Jiangsu Hansoh Pharmaceutical ...

GC Biopharma reported a return to profitability in the first quarter of 2025, driven by improved blood product margins in ...

Pfizer Korea has secured reimbursement for Lorviqua (lorlatinib) as a first-line treatment for ALK-positive metastatic ...

The Korean Diabetes Association (KDA) has removed metformin as the preferred first-line treatment for type 2 diabetes in its newly revised 2025 Clinical Practice Guidelines for Diabetes, citing a lack ...

Dong-A Socio Holdings posted a 31 percent jump in first-quarter operating profit, powered by an 854 percent surge at ...

Korean patients with atopic dermatitis (AD) -- the most common form of eczema -- aren’t short on complaints, but for many, it ...